Aflibercept and navigated versus conventional laser in diabetic macular edema: a 12-month prospective, randomized clinical trial

被引：0
|
作者：
Blindbaek, Soren Leer [1 ,2 ]
Peto, Tunde [2 ,3 ]
Grauslund, Jakob [1 ,2 ]
机构：
[1] Odense Univ Hosp, Ophthalmol, Odense C, Funen, Denmark
[2] Univ Southern Denmark, Clin Res, Odense, Funen, Denmark
[3] Queens Univ Belfast, Ctr Publ Hlth, Belfast, Antrim, North Ireland
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2019年 / 60卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
2627
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Effectiveness of intravitreal aflibercept injections for anti-VEGF treatment-naive patients with diabetic macular edema in UK routine clinical practice (DRAKO): 12-month results
    Sivaprasad, Sobha
    Ghanchi, Faruque
    Kelly, Simon P.
    Kotagiri, Ajay
    Talks, James S.
    Scanlon, Peter Henry
    Saddiq, Moneeb
    Napier, Jackie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [42] 12-month results of the standardised combination therapy for diabetic macular oedema: intravitreal bevacizumab and navigated retinal photocoagulation
    Barteselli, Giulio
    Kozak, Igor
    El-Emam, Sharif
    Chhablani, Jay
    Cortes, Marco A.
    Freeman, William R.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2014, 98 (08) : 1036 - 1041
  • [43] Comparison of ranibizumab, aflibercept, and dexamethasone implant monotherapy in treatment-naive eyes with diabetic macular edema: A 12-month real-life experience
    Parca, Osman
    Cetin, Ebru N.
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (SUPPL 3) : S453 - S458
  • [44] A 12-month Prospective Study to Evaluate the Efficacy of Treat and Extend Regimen (T&E) of Intravitreal Aflibercept as a Second-Line Treatment for Diabetic Macular Edema (TADI Study)
    Jaouni, Tareq Ziad
    Ehrlich, Rita
    Barak, Yoreh
    Katz, Haia
    Pokroy, Russell
    Levy, Jaime
    Hanhart, Joel
    Segal, Ori
    Shulman, Shiri
    Goldstein, Michaella
    Tiossano, Liran
    Chowers, Itay
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [45] Modified penetrating deep sclerectomy versus conventional trabeculectomy for the treatment of glaucoma: A 12-month randomized prospective study
    Xu, Zhike
    Wang, Lixiang
    Wei, Xin
    ACTA OPHTHALMOLOGICA, 2025,
  • [46] Clinical Evaluation and Treatment Accuracy in Diabetic Macular Edema Using Navigated Laser Photocoagulator NAVILAS
    Kozak, Igor
    Oster, Stephen F.
    Cortes, Marco A.
    Dowell, Dennis
    Hartmann, Kathrin
    Kim, Jae Suk
    Freeman, William R.
    OPHTHALMOLOGY, 2011, 118 (06) : 1119 - 1124
  • [47] Outcomes With As-Needed Aflibercept and Macular Laser Following the Phase III VISTA DME Trial: ENDURANCE 12-Month Extension Study
    Wykoff, Charles C.
    Le, Ryan T.
    Khurana, Rahul N.
    Brown, David M.
    Ou, William C.
    Wang, Rui
    Clark, W. Lloyd
    Boyer, David S.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 173 : 56 - 63
  • [48] Outcomes With As-Needed Aflibercept and Macular Laser Following the Phase III VISTA DME Trial: ENDURANCE 12-Month Extension Study
    Calugaru, Dan
    Calugaru, Mihai
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 177 : 235 - 236
  • [49] Brolucizumab versus Aflibercept in Patients with Diabetic Macular Edema: A Meta-Analysis of Randomized Controlled Trials
    Justino, Leonardo B.
    Justino, Gustavo B.
    Graffunder, Fabrissio P.
    Binotti, William W.
    Khodor, Ali
    Caranfa, Jonathan
    CLINICAL OPHTHALMOLOGY, 2024, 18 : 3679 - 3690
  • [50] Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial
    Wells, John A.
    Glassman, Adam R.
    Ayala, Allison R.
    Jampol, Lee M.
    Bressler, Neil M.
    Bressler, Susan B.
    Brucker, Alexander J.
    Ferris, Frederick L.
    Hampton, G. Robert
    Jhaveri, Chirag
    Melia, Michele
    Beck, Roy W.
    OPHTHALMOLOGY, 2016, 123 (06) : 1351 - 1359
12345